Skip to main content

Table 1 patient characteristics, including survival outcomes

From: Patient-reported outcome (PRO) results from the AGITG DOCTOR trial: a randomised phase 2 trial of tailored neoadjuvant therapy for resectable oesophageal adenocarcinoma

Characteristic

PET responders: CF (N = 45)

PET non-responders randomised: DCF (N = 31)

PET non-responders randomised: DCF + radiation (N = 35)

Others (N = 13)

All patients (N = 124)

Age in years, median (range)

61 (42–78)

60 (38–77)

63 (44–76)

65 (41–71)

63 (38–78)

Male

41 (91)

27 (87)

32 (91)

10 (77)

110 (89)

ECOG 0

37 (82)

25 (81)

27 (77)

13 (100)

102 (82)

Days between start of chemotherapy and surgery, mean (SD)

69 (10)

117 (19)

126 (24)

57 (22)

 

PFS in months, Median (95% CI)

27 (12–.)

22 (14–27)

22 (14–.)

13 (5–.)

22 (15–36)

OS in months, Median (95% CI)

61 (26–.)

30 (17–55)

35 (20–.)

31 (5–.)

36 (25–61)

Baseline QLQ-C30 and QLQ-OES18 scores per scale, mean (SD)

 Physical functioning

94 (10)

94 (12)

96 (9)

89 (13)

94 (10)

 Role functioning

88 (22)

82 (29)

90 (16)

85 (20)

87 (22)

 Emotional functioning

76 (23)

74 (21)

74 (19)

81 (16)

75 (21)

 Cognitive functioning

86 (17)

91 (20)

89 (14)

94 (11)

89 (16)

 Social functioning

78 (28)

75 (29)

80 (23)

79 (26)

78 (27)

 Fatigue

19 (20)

24 (20)

19 (19)

25 (21)

21 (20)

 Nausea and vomiting

8 (14)

16 (26)

11 (14)

12 (17)

11 (18)

 Pain

17 (21)

15 (22)

14 (16)

26 (19)

17 (20)

 Dyspnoea

10 (15)

9 (22)

7 (18)

8 (15)

9 (18)

 Insomnia

29 (33)

22 (29)

24 (26)

36 (29)

27 (30)

 Appetite loss

17 (23)

23 (30)

24 (23)

31 (29)

22 (26)

 Constipation

12 (22)

14 (19)

13 (18)

23 (34)

14 (22)

 Diarrhoea

5 (14)

5 (12)

3 (10)

5 (13)

5 (12)

 Financial difficulties

23 (24)

26 (31)

29 (31)

18 (29)

25 (28)

 Global health status/QoL

74 (18)

75 (15)

72 (16)

74 (15)

74 (16)

 Dysphagia

22 (23)

27 (20)

25 (23)

21 (19)

24 (22)

 Problems with eating

27 (24)

40 (28)

38 (27)

46 (31)

35 (27)

 Reflux

17 (18)

23 (28)

21 (27)

27 (24)

21 (24)

 Pain (OES-18)

22 (23)

21 (22)

23 (21)

23 (18)

22 (21)

 Trouble swallowing saliva

13 (24)

17 (28)

14 (28)

15 (26)

14 (26)

 Choked when swallowing

9 (15)

12 (28)

21 (28)

13 (22)

14 (23)

 Dry mouth

12 (18)

35 (33)

19 (30)

13 (22)

19 (27)

 Trouble with taste

4 (13)

9 (20)

16 (28)

10 (16)

9 (20)

 Trouble with coughing

9 (21)

15 (27)

11 (22)

8 (15)

11 (22)

 Trouble with talking

3 (10)

4 (14)

6 (20)

5 (13)

4 (14)